These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 859645)

  • 41. Editorial: Role of the kidney in the metabolism of calciferol (vitamin D).
    Coburn JW; Norman AW
    Clin Nephrol; 1973; 1(5):273-83. PubMed ID: 4358418
    [No Abstract]   [Full Text] [Related]  

  • 42. [Recent aspects on regulation of calcium metabolism. I. Vitamin D].
    Nielsen SP
    Ugeskr Laeger; 1973 Nov; 135(46):2504-7. PubMed ID: 4361021
    [No Abstract]   [Full Text] [Related]  

  • 43. Absorption of calcium, magnesium and phosphate during chronic renal failure and the effect of vitamin D in rabbits.
    Tvedegaard E
    Z Versuchstierkd; 1985; 27(3-4):163-8. PubMed ID: 4050164
    [No Abstract]   [Full Text] [Related]  

  • 44. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 45. Regulation of intestinal calcium absorption in the laying quail: independent of kidney vitamin D hydroxylation.
    Bar A; Eisner U; Montecuccoli G; Hurwitz S
    J Nutr; 1976 Sep; 106(9):1336-42. PubMed ID: 182938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The action of vitamin D2 and of 25-hydroxy-cholecalciferol on calcemia and urinary calcium excretion in the alcoholic cirrhotic (author's transl)].
    Vesin P
    Nouv Presse Med; 1978 Apr; 7(16):1373-5. PubMed ID: 307732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 1 alpha-hydroxyvitamin D3 treatment of therapy-resistant symptomatic hypocalcemia in a hypoparathyroid patient with intestinal malabsorption.
    Hylander E; Madsen S
    Acta Med Scand; 1979; 205(7):603-5. PubMed ID: 474189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Vitamin D deficiency and its correction in children with terminal stage of chronic kidney failure].
    Tsybysheva AK; Burkov IV; Blazhevich NV; Pereverzeva OG; Spirichev VB
    Vopr Med Khim; 1988; 34(4):112-7. PubMed ID: 3264096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in vitamin D metabolism as they pertain to chronic renal disease.
    Coburn JW; Hartenbower DL; Brickman AS
    Am J Clin Nutr; 1976 Nov; 29(11):1283-99. PubMed ID: 187055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1,25-dihydroxycholecalciferol in hypoparathyroidism.
    Davies M; Taylor CM; Hill LF; Stanbury SW
    Lancet; 1977 Jan; 1(8002):55-9. PubMed ID: 63708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Postoperative hypoparathyroidism: calcium and phosphate metabolism and serum 25-hydroxycholecalciferol and the effectiveness of treatment with vitamin D3].
    Sawicki A; Lorenc R; Wasilewska-Dziubińska E; Lukaszkiewicz J
    Endokrynol Pol; 1985; 36(4):197-204. PubMed ID: 3007076
    [No Abstract]   [Full Text] [Related]  

  • 52. Metabolic effects of 1alpha-hydroxycholecalciferol on renal osteodystrophy.
    Castells S; Shai F; Gauthier B; Hashemi SE; Reddy CM; De Luca HF
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):410-9. PubMed ID: 817872
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hypoparathyroidism in adults (author's transl)].
    Vagneur JP; Argémi B; Codaccioni JL; Simonin R
    Ann Endocrinol (Paris); 1978; 39(5):373-85. PubMed ID: 742836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.
    Tougaard L; Sorensen E; Brochner-Mortensen J; Christensen MS; Rodbro P; Sorensen AW
    Lancet; 1976 May; 1(7968):1044-7. PubMed ID: 57451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Intestinal calcium absorption in the early stage of renal insufficiency and the effect of 5,6-trans-25-OHCC].
    Werner E; Malluche HH; Ritz E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1305-7. PubMed ID: 611840
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapeutic use of vitamin D, its derivatives and their analogs].
    Vagneur JP; Argemi B
    Diabete Metab; 1982 Mar; 8(1):65-7. PubMed ID: 6980150
    [No Abstract]   [Full Text] [Related]  

  • 58. Short-term effects of 1,25-dihydroxycholecalciferol on disordered calcium metabolism of renal failure.
    Brickman AS; Coburn JW; Norman AW; Massry SG
    Am J Med; 1974 Jul; 57(1):28-33. PubMed ID: 4600292
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of hydrochlorothiazide on calcium metabolism in postoperative hypoparathyroidism].
    Sawicki A
    Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):501-3. PubMed ID: 1962853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Therapy with vitamin D and D-metabolites].
    Flury W; Haldimann B
    Schweiz Med Wochenschr; 1981 Feb; 111(9):314-21. PubMed ID: 6261326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.